Monoclonal antibodies of IKO series in the three-color analysis of sub-populations of peripheral blood T-lymphocytes of oncological patients
https://doi.org/10.17650/1726-9784-2018-17-2-47-56
Abstract
Background. Clinical studies have shown that the most oncological patients have impaired immunological reactivity. Monitoring of the immune system status of patients with solid tumors includes a subpopulation analysis of immunocompetent cells. It is based on the study of expression of surface antigens and intracellular structures, and an analysis of the functional activity of immunocompetent cells. Today two, three, and even four-color reagents are used for subpopulation analysis of lymphocytes. Fluorescent conjugate with monoclonal antibodies (MAB) of the ICO series and fluorescent dyes Imd-306, Imd-506 (cyanine) and phycoerythrin (a group of phycobiliproteins) was received and characterized in N.N. Blokhin National Medical Research Center of Oncology. These conjugates have proved themselves in one and two-color analysis of subpopulations of peripheral blood lymphocytes by flow cytometry.
The purpose of this study is to assess the possibility of sharing several immunofluorescent probes (IFP) on the basis of different Mab series of ICO and dyes FITC, Imd306, Imd506 and PE for three-color analysis of lymphocyte subpopulations of donors and patients with oncological diseases by flow cytometry method.
Materials and methods. A panel of immunofluorescent probes (IFP) CD3FITC, CD4PE, CD8-Imd506, CD4-Imd306 was used in the work. Probes are obtained with MAB (ICO series) and fluorophores FITC, PE, Imd-306, Imd-506. The specific activity of the probes was evaluated in the immunofluorescence reaction by flow cytometry. Donor’s peripheral blood was used to optimize the conditions of the immunofluorescence reaction. Clinical approbation of the obtained sets was carried out on 2 groups of patients with oncological diseases before and after surgical treatment. The first group included 64 patients with cancer of the oral mucosa. The second group consists of 35 patients with ovarian cancer.
Results. We have shown that for the three-color analysis of human lymphocytes by flow cytometry, it is recommended to use sets of labeled MAB: CD3-FITC (10 μg/ml) + CD4-Imd306 at a concentration of 5–10 μg/ml; CD3-FITC + CD4-PE at a concentration of 20 μg/ml and CD3-FITC + CD8 Imd506 at a concentration of 10 μg/ml. The final concentration of immunoglobulin in the solution of IPS is indicated. It was shown that even before the beginning of treatment in patients with cancer of the oral mucosa the subpopulation CD3+ CD4+ content was significantly lowered in the structure of T cells, and the total level of CD8+ lymphocytes significantly exceeds the parameters of the donor group. Analysis of linear CD markers of lymphoid cells in patients with ovarian cancer revealed a significant decrease in the total number of CD3+ T-lymphocytes in comparison with donors. There was no evidence of the effect of surgical treatment on the subpopulation structure of lymphoid cells.
Conclusion. Combinations of fluorescent probes CD3-FITC/CD4-Imd306/CD8-Imd506 and CD3-FITC/CD4-PE/CD8-Imd506 can be used for trichromatic analysis by flow cytometry of the lymphocyte subpopulations of both healthy donors and cancer patients. Comparative studies of the specific activity of combinations of IFP based on Mab ICO series and reference commercial test systems (BD Biosciences) on lymphocytes of healthy donors and oncological patients (ovarian cancer, oral mucosa cancer) showed comparable results. The application of the obtained probes made it possible to reveal violations of the subpopulation structure of peripheral blood lymphocytes in patients with ovarian cancer and cancer of the oral mucosa, in particular, CD3 – /CD8+, CD3+/CD4+, CD3+.
About the Authors
E. N. ZakharovaRussian Federation
24 Kashirskoe Shosse, Moscow 115478
T. N. Zabotina
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
O. V. Korotkova
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
M. E. Kopyrulina
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
I. V. Panichenko
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
V. T. Tsiklauri
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
I. A. Zadеrenko
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
D. Yu. Blokhin
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
P. K. Ivanov
Russian Federation
24 Kashirskoe Shosse, Moscow 115478
References
1. Galaktionov V.G. Immunology: a textbook. Moscow: Publishing house of Moscow state University, 1998. 480 p. (In Russ.).
2. Artamonova E.V. The role of immunophenotyping of tumor cells in the diagnosis and prognosis of breast cancer: dis. ... doctor of medicine: 14.01.12. Moscow, 2003. 311 p. (In Russ.)
3. Borunova A.A., Chkadua G.Z., Zabotina T.N., Kadagidze Z.G. the Study of subpopulations of CD16+ lymphocytes in oncological patients on the background of vaccine therapy. Medical immunology 2006;8(2–3):334 (In Russ.)
4. Borunova A.A., Chkadua G.Z., Zabotina T.N., Demidov L.V. Immunophenotype of lymphocytes of patients with melanoma against the background of vaccine therapy. The Russian biotherapeutic journal 2005;4(1):8 (In Russ.)
5. Zabotina T.N., Ocheeva N.Yu., Korotkova O.V. et al. Evaluation of the functional activity of cells of the granulocyte-macrophage link of immunity in patients with cancer of the mucous membrane of the oral cavity. Materials of the VI Congress of oncologists and radiologists of CIS countries: thes. of rep. Dushanbe, 2010. P. 67–8 (In Russ.)
6. Zabotina T.N., Korotkova O.V., Borunova A.A. et al. Subpopulation structure of lymphocytes in patients with ovarian cancer. Vestnik RONC im. N.N. Blokhina = Bulletin of N.N. Blokhin Russian Cancer Research Center 2010;21(1):46–51 (In Russ.)
7. Kadagidze Z.G., Slavina E.G., Zabotina T.N. et al. Immunological profile of blood lymphocytes in cancer patients. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2013;12(2):38 (In Russ.)
8. Kadagidze Z.G., Chertkova A.I., Zabotina T.N. et al. Basic subpopulations of regulatory lymphocytes in patients with malignant melanoma and breast cancer. Immunologiya = Immunology 2014;35(2):64–7 (In Russ.)
9. Korovushkina K.A., Babaev A.A., Kotel’nikova T. V. et al. Assessment of immunity in tumors of the uterine body. Vestnik Nizhegorodskogo Universiteta im. N.I. Lobachevskogo = Bulletin of N.I. Lobachevsky Nizhny Novgorod University. 2010;2–2:653–8 (In Russ.)
10. Korotkova O.V., Zabotina T.N., Skotarenko L.V. et al. Subpopulations of lymphocytes in the peripheral blood of patients with breast cancer. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2011;10(3):95 (In Russ.)
11. Skotarenko L.V., Vorotnikov I.K., Kadagidze Z.G., Shamilov F.A. Features of T-cell immunity in breast cancer. Opukholi Zhenskoy Reproduktivnoy Sistemy = Tumors of the female reproductive system 2011;4:24–7 (In Russ.)
12. Dubinkin I.V., Podgornaya T.V., Donskov S.I. Monoclonal reagents anti-A and anti-B with new properties. Transfuziologiya = Transfusion medicine 2009;10(1–2):28 (In Russ.)
13. Dubinkin I.V., Gorshkova T.V., Kalandarov R.S., Donskov S.I. Obtaining and testing of monoclonal anti-DVI-antibodies. Transfuziologiya = Transfusion medicine 2009;10(1–2):27–8 (In Russ.)
14. Filatov A.V., Bachurin P.S., Markova N.A., Churakova N.E. A panel of monoclonal antibodies to antigens of human lymphocytes. Eksperimen tal’naya Onkologiya = Experimental Oncology 1989;11(2):29 (In Russ.)
15. Baryshnikov A.Yu., Frolova E.A., Leneva N.V. et al. Monoclonal antibodies ICO-105 to the in terleukin-2 receptor (antigen CD25). Vestnik RONC im. N.N. Blokhina = Bulletin of N.N. Blokhin Russian Cancer Research Center 1993;4(4):7–12 (In Russ.)
16. Queen A.M., Baryshnikov A.Yu., Vikha G.V. et al. Characteristics of monoclonal antibodies ICO-116 to the CD16 antigen on natural killer cells. Biotechnologiya = Biotechnology 1993;(11–12):61 (In Russ.)
17. Baryshnikov A.Yu., Blokhina N.G., Kadagidze Z.G. ICO-1 Monoclonal antibodies against the constant part of IA-like antigens. Eksperimental’naya Onkologiya = Experimental Oncology 1984;6:123 (In Russ.)
18. Zakharova E.N., Zabotina T.N., Chudinov A.V. et al. Two-color analysis of cell populations by flow cytometry meth using cyanide dye IMD-306. Materials of the all-Russian scientific-practical conference “Domestic anticancer drugs”: thes. of rep. Moscow, 2007. P. 66 (In Russ.)
19. Zakharova E.N., Ivanov P.K., Zabotina T.N. et al. Immunofluorescent probes based on ICO-31 monoclonal antibodies and IMD-506 cyanide dye for the analysis of cellular populations by flow cytometry. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2013; 12(4):27–32 (In Russ.)
20. Zakharova E.N., Ivanov P.K., Zabotina T.N. et al. Two-color analysis of cell populations by flow cytometry meth using ICO series MCA conjugated with cyanine dye IMD-306. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2014;13(1):17–21 (In Russ.)
21. Kaparulina M.E., Zakharova E.N., Zabotina T.N. et al. Technology development and properties of immunofluorescence probes labeled Alexa-488 for the analysis of cell populations by flow cytometry. Rossiysky Bioterapevtichesky Zhurnal = Russian Journal of Biotherapy 2018;17(1):70–5 (In Russ.)
22. Stewart C.C., Stewart S.J. Four colour compensation. Cytometry 1999;38(4):161–75. PMID: 10440854.
Review
For citations:
Zakharova E.N., Zabotina T.N., Korotkova O.V., Kopyrulina M.E., Panichenko I.V., Tsiklauri V.T., Zadеrenko I.A., Blokhin D.Yu., Ivanov P.K. Monoclonal antibodies of IKO series in the three-color analysis of sub-populations of peripheral blood T-lymphocytes of oncological patients. Russian Journal of Biotherapy. 2018;17(2):47-56. (In Russ.) https://doi.org/10.17650/1726-9784-2018-17-2-47-56